AzTrials
AzTrials

Shoulder PainSHOULDER-DIAPHNCT07334171

Inspiratory Muscle Strength and Diaphragm Thickness in People With Shoulder Pain in Tennis Players

An observational study of Shoulder Pain, run by Universidad Francisco de Vitoria at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This observational case-control study will compare inspiratory muscle function and diaphragm morphology between individuals with shoulder pain and asymptomatic controls. Participants will be allocated into two groups according to the presence or absence of shoulder pain. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Shoulder Pain
How many people
64 participants
Where
1 siteSpain
Study dates
1 Feb 2026to 20 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Adult racket sport players aged 18 to 60 years, both with and without non-specific shoulder pain, recruited from local sports clubs and university-related facilities.

Who may be able to join

  • Tennis player who suffered from non-specific shoulder pain
  • Training at least two times per week
  • Have experienced at least 1 episode of non-specific shoulder pain in the last month
  • A positive result on the following diagnostic tests: Neer Test and Jobe Test

Who cannot join

  • Having taken anti-inflammatories or muscle relaxants within the last 72 hours before the study
  • Pregnancy
  • Previous diagnosis of respiratory or neurological diseases
  • Previous surgeries, fractures, and dislocations in the dominant shoulder
  • Inability to follow instructions during the study
  • All those for whom measuring maximum inspiratory pressure is contraindicated: unstable angina, recent myocardial infarction (within 4 weeks of the even or myocarditis, uncontrolled systemic hypertension, recent pneumothorax, post-lung biopsy surgery of less than one week, postoperative abdominal or genitourinary surgery of less than 6 months, and urinary incontinence

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universidad Francisco de Vitoria

    Pozuelo de Alarcón, Madrid, 28223

Other trials in Spain

About this study

Official title: Inspiratory Muscle Strength and Diaphragm Thickness in Tennis Players With and Without Shoulder Pain: A Case-Control Study

This observational case-control study will compare inspiratory muscle function and diaphragm morphology between individuals with shoulder pain and asymptomatic controls. Participants will be allocated into two groups according to the presence or absence of shoulder pain.

Inspiratory muscle strength will be assessed by measuring maximal inspiratory pressure (MIP) using standardized procedures. Diaphragm thickness will be evaluated bilaterally using ultrasound imaging at the end of inspiration (Tins) and at the end of expiration (Texp).

Read more

Pain intensity will be assessed using the Visual Analog Scale (VAS). Upper limb disability will be evaluated using the QuickDASH questionnaire, including the activities of daily living module and the optional sports module.

All outcomes will be assessed in a single evaluation session. Between-group comparisons will be performed to analyze differences in inspiratory muscle strength, diaphragm thickness, pain intensity, and upper limb disability between participants with and without shoulder pain.

Conditions
Shoulder Pain
Keywords
Shoulder pain, diaphragm, Maximal inspiratory pressure, Ultrasound imaging
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07334171
Study groupRoleWhat they receive
Shoulder Pain GroupParticipants with shoulder pain
Healthy Control GroupParticipants without shoulder pain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal Inspiratory Pressure (MIP)

    Maximal inspiratory pressure measured in cmH₂O using a respiratory pressure meter as an indicator of inspiratory muscle strength.

    Measured: Single assessment at baseline visit

  2. Diaphragm thickness at inspiration

    Bilateral diaphragm muscle thickness measured by ultrasound imaging at the end of maximal inspiration (Tins)

    Measured: Single assessment at baseline visit

  3. Diaphragm thickness at expiration

    Bilateral diaphragm muscle thickness measured by ultrasound imaging at the end of maximal expiration (Texp).

    Measured: Single assessment at baseline visit

Secondary outcomes (3)
  1. Pain intensity (VAS)

    Shoulder pain intensity assessed using the Visual Analog Scale (VAS) ranging from 0 to 10, where 0 = no pain and 10 = worst imaginable pain; higher scores indicate worse pain

    Measured: Single assessment at baseline visit

  2. Upper limb disability - activities of daily living

    Upper limb disability in activities of daily living assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH-Core) questionnaire (11 items). Scores range from 0 to 100, where 0 = no disability and 100 = most severe disability; higher scores indicate worse disability.

    Measured: Single assessment at baseline visit

  3. Upper limb disability - sport

    Upper limb disability in sport activities assessed using the Quick Disabilities of the Arm, Shoulder and Hand Sport module (4 ítems). Scores range from 0 to 100, where 0 = no disability and 100 = most severe disability; higher scores indicate worse disability.

    Measured: Single assessment at baseline visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2026
  2. Study start1 Feb 2026
  3. Primary completion1 Mar 2026
  4. Study completion20 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07334171
Sponsor's protocol ID
SHOULDER-DIAPH-01
Acronym
SHOULDER-DIAPH
Status last verified
Apr 2026
First submitted
3 Jan 2026
Last updated
28 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: At this time, it is unclear whether individual participant data (IPD) will be shared. Data sharing will depend on institutional policies, ethical approvals, participant privacy considerations, and the feasibility of preparing de-identified datasets. A final decision will be made once data collection and analysis are completed.

Questions about this trial

What is this clinical trial studying?

An observational study of Shoulder Pain, run by Universidad Francisco de Vitoria at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal Inspiratory Pressure (MIP) (time frame: Single assessment at baseline visit). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in